1. Home
  2. AUGO vs AMRX Comparison

AUGO vs AMRX Comparison

Compare AUGO & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AUGO

Aura Minerals Inc.

N/A

Current Price

$72.76

Market Cap

3.9B

Sector

N/A

ML Signal

N/A

Logo Amneal Pharmaceuticals Inc.

AMRX

Amneal Pharmaceuticals Inc.

HOLD

Current Price

$14.50

Market Cap

4.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AUGO
AMRX
Founded
1946
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
4.0B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
AUGO
AMRX
Price
$72.76
$14.50
Analyst Decision
Strong Buy
Buy
Analyst Count
2
4
Target Price
$48.90
$13.25
AVG Volume (30 Days)
1.1M
3.8M
Earning Date
02-26-2026
02-27-2026
Dividend Yield
2.42%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.02
Revenue
$771,589,000.00
$2,934,959,000.00
Revenue This Year
$46.44
$9.99
Revenue Next Year
$39.06
$6.48
P/E Ratio
N/A
$902.37
Revenue Growth
41.07
9.50
52 Week Low
$14.69
$6.69
52 Week High
$76.80
$15.00

Technical Indicators

Market Signals
Indicator
AUGO
AMRX
Relative Strength Index (RSI) 66.07 66.41
Support Level $60.00 $14.36
Resistance Level $65.99 $14.99
Average True Range (ATR) 4.31 0.47
MACD -0.51 0.05
Stochastic Oscillator 76.13 70.21

Price Performance

Historical Comparison
AUGO
AMRX

About AUGO Aura Minerals Inc.

Aura Minerals Inc is a mid-tier gold and copper production company focused on the development and operation of gold and base metal projects in the Americas. The company's operating segments are its operating assets and include The Minosa Mine, the Apoena Mine, the Aranzazu Mine, the Almas Mine; and projects (Matupa, Tolda Fria, Borborema and Carajas Projects, and Corporate).

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Share on Social Networks: